Risperidon- und/oder Paliperidonimplantatformulierung

European patent · EP2529756 · In force

Register entry

Publication number
EP2529756
Application number
EP12170362
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 31, 2012
Published
Dec 5, 2012
Granted
May 19, 2021
Protection ends at the latest
May 30, 2032
Next annual fee due
May 31, 2026
IPC classes
A61K 47/34 (2017.01)
A61K 31/519 (2006.01)
Priority
WO PCT/EP2011/059000 31.05.2011
WO PCT/EP2011/059001 31.05.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  2. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  3. Jun 2, 2023

    Change

    Published in Swissreg on 02.06.2023

  4. Mar 30, 2022

    Change

    Published in Swissreg on 30.03.2022

  5. May 19, 2021

    Granted

    Published in Swissreg on 19.05.2021

Parties

Holder

LABORATORIOS FARMACEUTICOS ROVI, S.A.

c/Julián Camarillo, 35, 28037 Madrid, ES

Inventor

Franco Rodriguez, Guillermo

28037 Madrid, ES

Gutierro Aduriz, Ibon

28037 Madrid, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.